Europe Large Molecule Bioanalytical Testing Services Market Size, 2028

Europe Large Molecule Bioanalytical Testing Services Market Size, Share & Industry Trends Analysis Report By End-user (SMEs and Large Firms), By Test Type, By Type (ADA, Pharmacokinetics), By Phase, By Therapeutic Areas, By Country and Growth Forecast, 2022 - 2028

Published Date: November-2022 | Number of Pages: 122 | Format: PDF | Report ID: KBV-20912

Special Offering: Industry Insights | Market Trends | Highest number of Tables | 24/7 Analyst Support


COVID-19

Get in-depth analysis of the COVID-19 impact on the Europe Large Molecule Bioanalytical Testing Services Market

Market Report Description

The Europe Large Molecule Bioanalytical Testing Services Market would witness market growth of 9.4% CAGR during the forecast period (2022-2028).

By using specific laboratory investigations, validation entails proving that the method's performance characteristics are reliable and appropriate for the intended analytical applications. The criteria used it to validate the procedure are closely correlated to the acceptability of analytical findings.

It is widely recognized and known that the area of bioanalysis has grown to become an essential instrument in the process of finding and developing new drugs. Numerous assays, including those for significant metabolites, have been constantly created for NCEs over the past few decades to assist various phases of discovery and development. Additionally, a variety of analytical techniques are accessible for both generic and prescription medications.

Chronic diseases are the major cause of mortality and morbidity in Europe region, and research predicts that complicated conditions like diabetes & depression will impose an even higher burden in the future. Chronic disease is the leading cause of morbidity and mortality in Europe. A number of years ago, chronic diseases were thought of as an issue faced mostly by the wealthy and the older people. Today, people are aware that those of lower socioeconomic status, along with those of younger and middle-aged ages, are more likely to suffer from chronic diseases in countries with high incomes. The consequences for businesses are also very significant when such diseases occur.

The Germany market dominated the Europe Large Molecule Bioanalytical Testing Services Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $166.5 million by 2028. The UK market is exhibiting a CAGR of 8.5% during (2022 - 2028). Additionally, The France market would experience a CAGR of 10.2% during (2022 - 2028).

Based on End-user, the market is segmented into SMEs and Large Firms. Based on Test Type, the market is segmented into Bioavailability, ADME, PD, Bioequivalence, and Others. Based on Type, the market is segmented into ADA, Pharmacokinetics, and Others. Based on Phase, the market is segmented into Clinical and Pre-clinical (With Antibody and Without Antibody (ELISA Based Assay)). Based on Therapeutic Areas, the market is segmented into Oncology, Neurology, Infectious Diseases, Cardiology, and Others. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.

Free Valuable Insights: The Global Large Molecule Bioanalytical Testing Services Market will Hit $2.8 Billion by 2028, at a CAGR of 9.1%

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Laboratory Corporation Of America Holdings, IQVIA Holdings, Inc., Syneos Health, Inc., SGS S.A., Intertek Group PLC, Pace Analytical Services, LLC, ICON Plc, Charles River Laboratories International, Inc., and Thermo Fisher Scientific, Inc.

Scope of the Study

Market Segments Covered in the Report:

By End-user

  • SMEs
  • Large Firms

By Test Type

  • Bioavailability
  • ADME
  • PD
  • Bioequivalence
  • Others

By Type

  • ADA
  • Pharmacokinetics
  • Others

By Phase

  • Clinical
  • Pre-clinical
    • With Antibody
    • Without Antibody (ELISA Based Assay)

By Therapeutic Areas

  • Oncology
  • Neurology
  • Infectious Diseases
  • Cardiology
  • Others

By Country

  • Germany
  • UK
  • France
  • Russia
  • Spain
  • Italy
  • Rest of Europe

Key Market Players

List of Companies Profiled in the Report:

  • Laboratory Corporation Of America Holdings
  • IQVIA Holdings, Inc.
  • Syneos Health, Inc.
  • SGS S.A.
  • Intertek Group PLC
  • Pace Analytical Services, LLC
  • ICON Plc
  • Charles River Laboratories International, Inc.
  • Thermo Fisher Scientific, Inc.

Unique Offerings from KBV Research

  • Exhaustive coverage
  • The highest number of market tables and figures
  • Subscription-based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free

Related Reports:

Global Large Molecule Bioanalytical Testing Services Market Report 2022-2028

North America Large Molecule Bioanalytical Testing Services Market Report 2022-2028

Asia Pacific Large Molecule Bioanalytical Testing Services Market Report 2022-2028

LAMEA Large Molecule Bioanalytical Testing Services Market Report 2022-2028

Purchase Report

 1500
 1800
 2520

Special Pricing & Discounts

  • Buy Sections of This Report
  • Buy Country Level Reports
  • Request for Historical Data
  • Discounts Available for Start-Ups & Universities